Clinical Trials

HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines, and Shanghai Henlius Biotech, Inc., a global biopharmaceutical...

In-depth Analysis and Testing Unveil the Leading Brain-Boosting Supplements WholisticResearch, a leading authority in the realm of cognitive enhancement research, has recently unveiled its...

Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced the interim results for the six months ended 30 June 2023 (the period...

Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced that a phase 1/2 clinical trial of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised...

HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today...

 RenovoRx, Inc. ("RenovoRx") (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, and Imugene Ltd ("Imugene") (ASX: IMU), a clinical-stage immuno-oncology company, today announced a strategic...

Serving Patients and the General Public with High-quality Testing Services and Being a Trusted and Reliable Partner ADICON Holdings Limited (ADICON or Company, HKG: 9860),...

ADICON Holdings Limited (ADICON or Company, HKG: 9860), the pioneer of independent clinical laboratory (ICL) and one of the top three ICL service providers...

Avance Clinical, the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early phase biotech companies to speed up the...

Avance Clinical the leading award-winning Australian and North American CRO that offers the programs ClinicReady and GlobalReady for early phase biotech companies to speed...

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...

Avance Clinical the leading award-winning Australian and North American biotech CRO that offers a GlobalReady program to early phase biotech companies to speed up...

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that...

Essex Bio-Technology Ltd. (Essex or the Group, HKG: 1061) is pleased to announce that its wholly-owned subsidiary, Majeton Pte. Ltd. (Majeton), has entered into...

Essex Bio-Technology Ltd. (Essex or the Group, HKG: 1061) is pleased to announce that its wholly-owned subsidiary, Essex Medipharma (Zhuhai) Co., Ltd. (Essex Medipharma),...

The award-winning TrialWire(TM) Patient Recruitment Platform, the most secure and rapid digital patient recruitment solution to reverse failing recruitment, today announced the rollout of...

Apollomics' Class A ordinary shares and public warrants are expected to begin trading today on the Nasdaq Capital Market under the ticker symbols...

Cryoviva Singapore, reputed to be among the top family cord stem cell banking companies in Southeast Asia, is making a significant upgrade to its...

Resilience & Relevance, Growth Ready Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced the annual results for the year ended 31...

Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited (Essex Bio-Investment) and Zhuhai...